NAMS in the 13F filings
Newamsterdam Pharma Company · CUSIP N62509109
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 18 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 6 listed it in both
- Shares listed
- 37,193,919
- combined, among listed positions
- Reported value
- $1.2bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 13 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +3,409,103.
Managers listing NAMS in Q1 2026
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 8,765,811 shares now+2,352,827
- Capital World Investorsexisting position · 11,109,034 shares now+1,125,034
- Maverick Capital Ltdexisting position · 2,186,402 shares now+292,176
- Marshall Wace LLPnew position · 264,802 shares now+264,802
- Wellington Management Group LLPexisting position · 5,115,818 shares now+82,643
Reductions
- Jane Street Group LLCexisting position · 165,201 shares now-256,290
- Susquehanna International Group LLPexisting position · 17,825 shares now-177,810
- AllianceBernstein LPexisting position · 1,199,325 shares now-101,550
- Janus Henderson Group Ltdexisting position · 2,258,984 shares now-82,739
- Walleye Capital LLCexisting position · 58,434 shares now-37,827
New positions and exits
New (3)
Exited (6)
- T. Rowe Price Associates Incwas $4.1m
- Verition Fund Management LLCwas $1.1m
- Winton Group Ltdwas $1.0m
- Holocene Advisors LPwas $718k
- Polen Capital Management LLCwas $394k
- Quantbot Technologies LPwas $130k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2022 | 1 | $39m | n.a. | n.a. |
| Q1 2023 | 1 | $53m | n.a. | n.a. |
| Q2 2023 | 1 | $78m | n.a. | n.a. |
| Q3 2023 | 1 | $74m | n.a. | n.a. |
| Q4 2023 | 1 | $90m | 0 | 0 |
| Q1 2024 | 1 | $190m | 0 | 0 |
| Q2 2024 | 2 | $163m | 1 | 0 |
| Q3 2024 | 2 | $153m | 1 | 0 |
| Q4 2024 | 5 | $322m | 4 | 1 |
| Q1 2025 | 5 | $391m | 4 | 0 |
| Q2 2025 | 5 | $376m | 2 | 2 |
| Q3 2025 | 5 | $599m | 2 | 3 |
| Q4 2025 | 8 | $851m | 17 | 5 |
| Q1 2026 | 6 | $820m | 13 | 11 |
| Q2 2026 | 6 | $790m | 21 | 6 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
NAMS and LLY →NAMS and JNJ →NAMS and VRTX →Choose a stock to compare with NAMS →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own NAMS, latest filings →Back to the 13F Explorer →